Market value of pharmaceutical glass packaging estimated at
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) – The Global Anti-Allergic Drugs Market is expected to grow at a CAGR of approximately 5.3% from 2020 to 2027 and reach a market value of over US $ 33.2 billion by 2027.
Pharmaceutical packaging can be defined as packaging products manufactured using drug-compatible materials to provide protection, identification and ensure the integrity of the enclosed pharmaceutical product. Pharmaceutical packaging products are made using different kinds of raw materials, such as high and low molecular weight plastics, paper, glass, aluminum foil and others. Glass, plastics and aluminum are widely used in primary packaging depending on dosage forms and mode of drug delivery systems, while paper and cardboard are used for secondary packaging.
Glass plays an essential role in the primary packaging of pharmaceutical products. Glass limits the alkalinity and hydrolytic resistance of the glass container. In addition, glass containers provide high transparency, which allows easy inspection of its contents, provides protection as it is relatively impermeable to air and moisture, and chemical resistant to most drugs. Glass is a mixture of sand, sodium carbonate cullet, sodium carbonate limestone and a few other elements. Primary and secondary packaging are used to protect the contained product against mechanical, chemical, biological and climatic risks.
DOWNLOAD EXAMPLES OF PAGES FROM THIS REPORT @ https://www.acumenresearchandconsulting.com/request-sample/2695
Secondary packaging includes temperature-controlled packaging and cardboard boxes. The eradication of plastic in pharmaceutical packaging and the use of glass in pharmaceutical packaging and recycling of glass for future use would be a key factor in driving the growth of the pharmaceutical glass packaging market. The market is segmented into product type, drug type, material type, and region.
The North American market is expected to account for a significant revenue share in the global pharmaceutical glass packaging market and Europe is second after North America. The increasing use of injectable generic drugs, combined with the strong demand from the pharmaceutical industry, is driving the demand for the global pharmaceutical glass packaging market. Europe is expected to represent the second largest market share over the forecast period with growing medical advancements employing R&D in the region. Asia-Pacific is an emerging market and is expected to grow during the forecast period. The expansion of the generic pharmaceutical industry in countries like China and India due to the increase in population, increase in healthcare infrastructure and government involvement in the health sector. health are the driving forces of the region.
SEE THE TABLE OF CONTENTS OF THIS REPORT @ https://www.acumenresearchandconsulting.com/pharmaceutical-glass-packing-market
The need for packaging in this industry mainly depends on the increase in communicable and non-communicable diseases and their treatments, including Covid19. Pharmaceutical glass packaging products are highly regulated by governments to ensure drug protection from physical damage, drug contamination and safety. The growing demand for pharmaceuticals and technological advancements in this industry would directly lead to the growth of the market. Over 130 million tonnes of glass are currently produced each year, 40% of which is used in pharmacies and more than 70% recycled glass.
The additional impact of the COVID-19 pandemic is having a positive impact on the pharmaceutical industry and other healthcare establishments, this would lead to fuel the market for Pharmaceutical Glass Packaging. Demand is doubled after rapid approvals of vaccines developed by various pharmaceutical institutions and industries.
Browse upcoming market research reports @ https://www.acumenresearchandconsulting.com/forthcoming-reports
Developments in the pharmaceutical glass packaging market:
According to the Institute of Scrap Recycling Industries, Inc., recycled glass is the 70% substitute for the raw material used in the manufacture of new glass. Glass recycling initiatives add value to glass as a commodity.
In 2019, Corning Inc, the German glass production company introduced Corning Valor glass which improves the resistance and durability of glass to chemicals and is free of boron.
Gerresheimer AG, a German manufacturer of pharmaceutical glass packaging, has developed a metal-free 1ml long Gx RTF® Luer lock syringe. A study by Gerresheimer confirms that no ceramic residue can be detected in the syringe. A biocompatibility study also verifies that the ceramic material is not cytotoxic.
- The spindle used to shape the cone is made of special ceramic.
- Long 1 ml Luer lock Gx RTF syringe available commercially, other sizes on request.
INQUIRY BEFORE YOU BUY @ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2695
BUY THIS PREMIUM RESEARCH REPORT – https://www.acumenresearchandconsulting.com/buy-now/0/2695
Would like to place an order or any question, please feel free to contact at [email protected] | +1 407 915 4157
For the latest update, follow us: